Showing results (61-70 of 142) with videos related to
Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1983
Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibodyJ J Ryan, J J Mond, F D Finkelman, et al.Proceedings of the National Academy of Sciences of the United States of America|August 15, 1991
Anti-immunoglobulin stimulation of B lymphocytes activates src-related protein-tyrosine kinasesA L Burkhardt, M Brunswick, J B Bolen, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1986
In vitro and in vivo B lymphocyte-activating properties of monoclonal anti-delta antibodies. I. Determinants of B lymphocyte-activating propertiesD K Goroff, A Stall, J J Mond, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 1, 1990
Genetic analysis of the presentation of minor lymphocyte-stimulating determinants. II. Differing non-MHC control of super-stimulatory and more poorly stimulatory Mls phenotypesJ J Ryan, H B LeJeune, J J Mond, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1995
Multivalent, but not divalent, antigen receptor cross-linkers synergize with CD40 ligand for induction of Ig synthesis and class switching in normal murine B cells. A redefinition of the TI-2 vs T cell-dependent antigen dichotomyC M Snapper, M R Kehry, B E Castle, et al.Journal of Immunogenetics|February 1, 1988
Augmented in vitro presentation of Mls determinants after anti-immunoglobulin-induced B cell activation: ontogeny and role of purified B cellsJ J Ryan, C B Thompson, J J Mond, et al.Immunopharmacology|November 1, 1989
8-Mercaptoguanosine-mediated enhancement of in vivo IgG1, IgG2 and IgG3 antibody responses to polysaccharide antigens in normal and xid miceJ J Mond, K Hunter, J J Kenny, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1986
In vivo and in vitro expression of an interleukin 2 receptor by murine B and T lymphocytesF D Finkelman, T R Malek, E M Shevach, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1994
Treatment with dextran-conjugated anti-IgD delays the development of autoimmunity in MRL-lpr/lpr miceA Shirai, I Aoki, M Otani, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1991
Dextran-conjugated anti-Ig antibodies as a model for T cell-independent type 2 antigen-mediated stimulation of Ig secretion in vitro. I. Lymphokine dependenceL M Peçanha, C M Snapper, F D Finkelman, et al.Pageof 15